​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Outcomes for Floyd Center for Bariatric Surgery 

Floyd Center for Bariatric Services offers a multidisciplinary weight loss surgery program designed to enhance successful outcomes.  Surgery alone is not a reliable solution for obesity but instead should be offered within the context of:

• supportive, experienced bariatric nurse coordinators

• an experienced bariatric dietitian who sees patients before surgery and at every follow-up visit

• a network of specialists linked together to assure coordinated care

• a supportive hospital with experienced nurses and a high-definition laparoscopy suite

• an outcomes management program to assure ongoing quality improvement. 

Our surgery outcomes and comorbidities resolved are calculated using all surgery types. The comorbidities resolved are based on patient outcomes 12 months after surgery.  

Average Length of Stay

• Less than two days — Gastric Bypass 
  

• Less than 23 hours — Adjustable Gastric Banding
  

• One day — Sleeve Gastrectomy

Surgery Outcomes for All 2019 Surgeries

• 0 — Mortalities (deaths)

• 0 — Conversion to open (perfoming open surgery instead of laparoscopic)

• 0 — Admissions to ICU

• 3 — Readmissions

• 0 ​​​​—​ ​Deep t​iss​ue or organ space infections 

• ​1 — Superficial incision infection

• 0 — Venous thrombosis (blood clots) 

• 0 — PRBC transfusions (blood transfusions)

• 1 —Reoperation 

• 0 — Strictures (activity restrictions)

 Surgery Outcomes

Bariatric surgery has a greater impact than weight loss. The numbers below represent the percentage of our patients who had a disease prior to surgery but no longer suffer from that disease following surgery. Our outcomes trend higher than the national average mainly due our expert team's dedication to education, nutrition and after-surgery support.

Comorbidities Reduction for Sleeve Gastrectomy

The following outcomes are from patients who received sleeve gastrectomy at Floyd Medical Center in 2017.

• Type 2 diabetes — 83.3%
  (66.2% national average)

• Sleep apnea — 73.3%
  (51.6% national average)

• Hyperlipidemia (fats in the blood)​ — 75%
  (39.2% national average)

• Hypertension (high blood pressure) — 64.7%
  (45.1% national average)
  

• GERD (gastroesophageal reflux disease) — 54.5%
  (18% national average)
  

• Overall reduction of one or more comorbidities — 84.6%
  (74.2% national average)
  

​Comorbidities Reduction for Gastric Bypass

The following outcomes are from patients who received gastric bypass at Floyd Medical Center in 2017.

• Type 2 diabetes — 92%
  (71.5% national average)

• Sleep apnea — 63.6%
  (55.2% national average)

• Hyperlipidemia — 62.5%
  (52.4% national average)

• Hypertension — 44%
  (51.3% na​tional average)

• GERD — 92.9%
   (48.3% national average)

• Overall reduction of one or more comorbidities — 92.1%
  (81.9% national average)